Jonathan Newman is interviewed by Kerry Lutz on the Financial Survival Network.
ACOU085 (INN: Bimokalner) Completes Patient Enrollment in Phase 2 PROHEAR Study for Preventing Cisplatin-Induced Ototoxicity, Says Acousia January 8, 2026